author-photo

Andrea Pretta

University of Cagliari
Sapienza University of Rome

27

Papers

51

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Abstract 28: Prognostic value of baseline and early changes of circulating cell-free (cf)DNA in the neoadjuvant setting of early stage colon cancer (CC)

2021
Show All
- Source
- Cite
- Save
Citations (0)
490P New horizons in metastatic colorectal cancer: Role of CD44 expression

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PD-5 Retrospective comparative analysis of K-ras G12C vs other K-ras mutations in metastatic colorectal cancer patients treated with first-line chemotherapy doublet + bevacizumab

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P-129 Concomitant RAS and BRAF mutations: Impact on overall survival and progression free survival in metastatic colorectal cancer patients

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue

2021 Human Cell
Show All
- Source
- Cite
- Save
Citations (0)
P-128 Influence of anti-diabetic medications on the outcomes of patients with pancreatic ductal adenocarcinoma and type 2 diabetes mellitus

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Uncovering key targets of success for immunotherapy in pancreatic cancer.

2021 Expert Opinion on Therapeutic Targets
Show All
- Source
- Cite
- Save
Citations (0)
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus.

2020 Tumori
Show All
- Source
- Cite
- Save
Citations (1)
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (0)